Resident
Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne
Cologne, Germany
Moritz Fürstenau, MD, is a clinical trialist at the German CLL study group and a physician at the University Hospital Cologne, Germany. His main areas of research include phase 2 and 3 clinical trials in novel combination treatments, new methods of response assessment like NGS MRD, ctDNA, and radiomics in CLL.
YIM Session 4: Clinical Approach Considerations and Treatment Options in CLL
Friday, September 12, 2025
12:45 - 13:50 CEST
